CXCL13 Activation of c-Myc Induce RANK Ligand Expression in Stromal/Preosteoblast Cells in the Oral Squamous Cell Carcinoma Tumor-Bone Microenvironment

CXC chemokine ligand-13 (CXCL13) has been implicated in oral squamous cell carcinoma (OSCC) tumor progression and osteolysis. Tumor necrosis factor family member, RANKL (receptor activator of NF-κB ligand), a critical bone resorbing osteoclastogenic factor plays an important role in cancer invasion...

Descripción completa

Detalles Bibliográficos
Autores principales: Sambandam, Yuvaraj, Sundaram, Kumaran, Liu, Angen, Kirkwood, Keith L., Ries, William L., Reddy, Sakamuri V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355224/
https://www.ncbi.nlm.nih.gov/pubmed/22330139
http://dx.doi.org/10.1038/onc.2012.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355224/
https://www.ncbi.nlm.nih.gov/pubmed/22330139
http://dx.doi.org/10.1038/onc.2012.24

Ejemplares similares